Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance

被引：0
|
作者：
Xinlin Jiao
Siying Zhang
Jun Jiao
Teng Zhang
Wenjie Qu
Guy Mutangala Muloye
Beihua Kong
Qing Zhang
Baoxia Cui
机构：
[1] Qilu Hospital,Department of Obstetrics and Gynecology
[2] Shandong University,Gynecology Oncology Key Laboratory
[3] Qilu Hospital,undefined
[4] Shandong University,undefined
来源：
Clinical Epigenetics | 2019年 / 11卷
关键词：
Cervical cancer; SEPT9; Methylation; HMGB1-RB axis; Radio-resistance; TAMs polarization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance
    Jiao, Xinlin
    Zhang, Siying
    Jiao, Jun
    Zhang, Teng
    Qu, Wenjie
    Muloye, Guy Mutangala
    Kong, Beihua
    Zhang, Qing
    Cui, Baoxia
    [J]. CLINICAL EPIGENETICS, 2019, 11 (01)
  • [2] Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future
    Li, Yuemin
    Song, Lele
    Gong, Yuan
    He, Baoming
    [J]. BIOMARKERS IN MEDICINE, 2014, 8 (05) : 755 - 769
  • [3] Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection
    Wang, Yu
    Chen, Pei-Min
    Liu, Rong-Bin
    [J]. WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 10 (01) : 15 - 22
  • [4] Advance in plasma SEPT9 gene methylation assay for colorectal cancer early detection
    Yu Wang
    Pei-Min Chen
    Rong-Bin Liu
    [J]. World Journal of Gastrointestinal Oncology, 2018, 10 (01) : 15 - 22
  • [5] Promoter methylation analysis of DKK2 may be a potential biomarker for early detection of cervical cancer
    Zhang, Xian
    Li, Aihua
    Wu, Jie
    Wu, Yu
    Ma, Xiaoping
    Liu, Yanjun
    Chen, Qingfa
    Zhang, Yan
    [J]. ASIAN BIOMEDICINE, 2022, 16 (04) : 181 - 189
  • [6] Promoter Methylation of QKI as a Potential Specific Biomarker for Early Detection of Colorectal Cancer
    Zhang, Lei
    Li, Dapeng
    Gao, Lijing
    Fu, Jinming
    Sun, Simin
    Huang, Hao
    Zhang, Ding
    Jia, Chenyang
    Zheng, Ting
    Cui, Binbin
    Liu, Yanlong
    Zhao, Yashuang
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [7] Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population
    Lima, Adhara Brandao
    dos Reis, Mariana Bisarro
    Matsushita, Marcus
    dos Reis, Monise Tadin
    de Oliveira, Marco Antonio
    Reis, Rui Manuel
    Guimaraes, Denise Peixoto
    [J]. CANCER MEDICINE, 2023, 12 (15): : 15854 - 15867
  • [8] Promoter SEPT9 V3 DNA Methylation in Premalignant and Malignant Colon Patients: A Biomarker from Tissue in Plasma
    Toth, K.
    Kalmar, A.
    Wichmann, B.
    Tulassay, Z.
    Molnar, B.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (06): : 699 - 699
  • [9] Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker
    Ravegnini, Gloria
    Zolezzi Moraga, Juan Manuel
    Maffei, Francesca
    Musti, Muriel
    Zenesini, Corrado
    Simeon, Vittorio
    Sammarini, Giulia
    Festi, Davide
    Hrelia, Patrizia
    Angelini, Sabrina
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (12): : 28486 - 28497
  • [10] Promoter hypermethylation of SHOX2 and SEPT9 is a potential biomarker for minimally invasive diagnosis in adenocarcinomas of the biliary tract
    V. Branchi
    P. Schaefer
    A. Semaan
    A. Kania
    P. Lingohr
    J. C. Kalff
    N. Schäfer
    G. Kristiansen
    D. Dietrich
    H. Matthaei
    [J]. Clinical Epigenetics, 2016, 8
12345